• Aerospace
  • Agriculture
  • Consumer Services
  • Healthcare
  • Energy And Resources
  • Food & Beverages
  • Electric Equipments
  • Materials And Chemicals
  • Semiconductor
  • Technology And Media
  • Transportation And Shipping
  • Automobile & Transportation
  • Chemical & Material
  • Medical Devices
  • Banking
  • Drugs By Therapeutics Area
  • Oncology Drugs
  • Therapeutics Area
  • Healthcare services
  • Diagnostics
  • Laboratory Equipment
  • Metals And Minerals
  • Rubber
  • Consumer Electronics
  • Personal care products
  • Travel And Tourism
  • Energy & Power
  • Computing And Technology
  • Electronics
  • Food Ingredients
  • Military
  • Defense
  • Machinery & Equipment
  • Heavy Industries
  • Industrial Automation
  • Asia Pacific
  • Pharmaceutical
  • NanoTechnology
  • Vaccines
  • Consumer Goods
  • Others
  • Service & Software
IL-6 Receptor Antagonist

IL-6 Receptor Antagonist

Date: Jan-2019 | Id: MACRC-0999 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “IL-6 Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A ke...

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor

Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor

Date: Jan-2019 | Id: MACRC-0920 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Cyclin-Dependent Kinase 6/4 (CDK6/4) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism...

BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors

BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors

Date: Jan-2019 | Id: MACRC-0872 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “BRAFV600 mutation (B-Raf proto-oncogene, serine/threonine kinase) Inhibiotors-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipel...

Alpha v Beta 3/5/6 Integrin Antagonist

Alpha v Beta 3/5/6 Integrin Antagonist

Date: Jan-2019 | Id: MACRC-0809 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “Alpha v Beta 3/5/6 Integrin Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of acti...

5-HT6 Antagonist

5-HT6 Antagonist

Date: Jan-2019 | Id: MACRC-0786 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. CmaxInsight’s, “5-HT6 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA). A key object...

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)

Date: Jan-2019 | Id: MACRC-0724 | Geographical Scope: Global

This report can be delivered to the clients within 1-2 Business Days. “Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1)-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across thi...

United States Pneumonia Vaccine Market

United States Pneumonia Vaccine Market

Date: Jan-2020 | Id: MACRC-0116 | Geographical Scope: United States

The United States Pneumonia Vaccines Market Size Worth Over USD 9 Billion by 2026.

Global Diabetes Insulin Delivery Pen Market

Global Diabetes Insulin Delivery Pen Market

Date: Jan-2020 | Id: MACRC-0115 | Geographical Scope: Global

The Global Diabetes Insulin Delivery Pen Market size is expected to exceed US$ 20 billion by 2026.

India Outbound MICE Tourism Market

India Outbound MICE Tourism Market

Date: Jan-2020 | Id: MACRC-0114 | Geographical Scope: India

India Outbound Meetings, Incentives, Conferences and Exhibitions (MICE) tourism market size is set to surpass US$ 11 billion by 2026.

China Outbound Tourism Market to GCC Countries

China Outbound Tourism Market to GCC Countries

Date: Jan-2020 | Id: MACRC-0113 | Geographical Scope: China

China outbound tourism market size to GCC countries is expected to generate revenues of more than US$ 9 billion by 2026.